Abstract. Hepatic growth factor (HGF) has neurotrophic effects in the motor neurons and central nervous system. However, there has been no report about the neurotrophic action on perivascular nerves innervating the resistance artery. We investigated whether HGF can restore innervation or function of perivascular nerves, including neuropeptide Y (NPY)-containing sympathetic adrenergic nerves and calcitonin gene-related peptide (CGRP)-containing nerves, in rat mesenteric artery. To investigate HGF-mediated neurotrophic effects, Wistar rats under pentobarbital-Na anesthesia underwent in vivo perivascular denervation by topical application of phenol on the superior mesenteric artery, and then HGF or nerve growth factor (NGF) was administered for 7 days using an osmotic mini-pump after phenol-treatment. HGF significantly increased the density and number of CGRP-like immunoreactivity (LI)-containing nerve fibers compared with saline administration, while HGF did not affect the density of NPY-containing adrenergic nerve fibers. After 7-day treatment with HGF and phenol, the vascular response of vasodilation was recovered from nerve injury by phenol treatment, but vasoconstriction was not. HGF and NGF induced neurite outgrowth in rat cultured dorsal root ganglia (DRG). These results suggest that HGF has a specific neurotrophic action on reinnervation of vascular CGRP-LIcontaining nerve fibers in the rat mesenteric artery and DRG.
Introduction
Human hepatic growth factor (HGF) was first purified from the plasma of patients with fulminant hepatic failure (1, 2) . There are many reports that HGF is associated with endothelial function. HGF is well known as an endothelium-specific growth factor that plays a role as a basic fibroblast factor and survival factor in endothelial cells (3) . Another report suggested that HGF prevents endothelial cell death under high glucose conditions (4) . Although endothelial function of HGF has been demonstrated, the effect of perivascular nerve function is less well understood.
HGF has been shown to have neurotrophic activities in the cerebral cortex, sensory neurons, and spinal cord motor neurons (5 -7) . In the peripheral nervous system, HGF has also been reported to have a neurotrophic effect on adult motor neurons after axotomy of the hypoglossal nerves in vivo (8) . However, it remains unclear whether HGF has trophic effects on peripheral perivascular nerves.
Perivascular nerves play an important role in maintenance of vascular tone along with endothelial cells. The mesenteric artery, which comprises the largest vascular bed in the body, is innervated by many perivascular nerves, such as sympathetic adrenergic nerves, and non-adrenergic non-cholinergic nerves, which include calcitonin gene-related peptide (CGRP)-containing nerves (CGRPergic nerves) (9) . Recently, we demonstrated that innervation of CGRPergic nerves and neuropeptide Y (NPY)-containing sympathetic adrenergic nerves in rat mesenteric resistance arteries was markedly reduced by topical application of phenol in vivo and that nerve growth factor (NGF) facilitates reinnervation of both types of nerves (10) . Furthermore, we recently demonstrated that adrenomedullin, a vasoactive peptide, has the ability to facilitate reinnervation of mesenteric perivascular nerves lesioned by topical treatment with phenol (11, 12) .
Therefore, the present study was designed to investigate whether HGF has neurotrophic activities on the reinnervation of mesenteric perivascular nerves after in vivo denervation by using topical treatment with phenol. To further investigate the neurotrophic effect of HGF, the density of innervation of perivascular nerves, neurogenic vascular responses of the rat mesenteric resistance artery and in vitro neurite outgrowth in primary cultures of dorsal root ganglia (DRG) were examined.
Materials and Methods

Experimental animals
Eight-week-old Wistar rats (purchased from Shimizu Experimental Animals, Shizuoka) were used in this study. The animals were given food and water ad libitum. They were housed in the Animal Research Center of Okayama University at a controlled ambient temperature of 22°C with 50 ± 10% relative humidity and with a 12-h light / 12-h dark cycle (lights on at 8:00 AM). All animal experimental procedures were approved by the Committee on Animal Experiments at Okayama University and carried out in accordance with the Guidelines for Animal Experiments at Okayama University Advanced Science Research Center, Japanese Government Animal Protection and Management Law (No. 105) and the Japanese Government Notification on Feeding and Safekeeping of Animals (No. 6). Every effort was made to minimize the number of animals used and their suffering.
Animal treatments and experimental protocols
After anesthesia with sodium pentobarbital (50 mg/kg, intraperitoneally), an abdominal midline incision was made in the animal, and the superior mesenteric artery proximal to the bifurcation from the abdominal aorta was exposed and topically swabbed with 10% phenol solution (in 90% alcohol-saline) using a cotton bud, as described previously (11 -13) . Sham-operated rats underwent the same surgical procedures except they were swabbed with the vehicle (saline or 90% alcohol without phenol). After swabbing, an antibiotic (penicillin G; Sigma Aldrich Japan, Tokyo) was infused around the surgical area and the incision was closed. After the operation, the animals were transferred into their individual cages in a temperature-controlled room and received intramuscular injection of penicillin G (3.1 mg / kg) for 3 consecutive days. After phenol treatment and a sham operation, the animals were killed by deep anesthesia on Day 7 for use in the experiments described below.
After the swabbing described above, a mini-osmotic pump (model 2001; Alzet, Alza, Palp Alto, CA, USA) was implanted in the abdominal area to administer recombinant human HGF (Mitsubishi Pharmaceutical Co., Tokyo) at a rate of 10 or 30 μg / kg per day and NGF (Sigma Aldrich Japan) at a rate of 20 μg / kg per day for a period of 7 days. HGF was dissolved in PBS containing 0.005% Triton-X and NGF was dissolved in sterile saline and injected into Alzetosmotic min-pumps. Control animals were implanted with mini-pumps containing saline. The animals were randomly divided into five groups: 1) a normal control Sham group (Sham); 2) a phenol-saline group (Ph + Saline), animals receiving saline after phenol treatment; 3) a phenol-HGF10 group (Ph + HGF10), animals receiving HGF 10 μg / kg per day after phenol treatment; 4) a phenol-HGF30 group (Ph + HGF30), animals receiving 30 μg/ kg per day after phenol treatment; 5) a phenol-NGF group (Ph + NGF), animals receiving NGF after phenol treatment.
Systolic blood pressure measurement
The systolic blood pressure of each animal was measured daily by tail-cuff plethysmography (model TK-370C; UNICOM, Tokyo) throughout the treatment period.
Immunohistochemical study
The animals treated topically with phenol or vehicle were anesthetized with a large dose of sodium pentobarbital (50 mg/kg, intraperitoneally). The superior mesenteric artery was cannulated with polyethylene tubing and Zamboni solution (2% paraformaldehyde and 15% picric acid in 0.15 M phosphate buffer) was infused. Then, the mesenteric artery was removed together with the intestine as described previously (11 -13) . The third branch of the mesenteric artery proximal to the intestine was immersion-fixed in the Zamboni solution for 48 h, immersed in PBS containing 0.5% TritonX-100 overnight, and incubated with PBS containing normal goat serum (1:100) for 60 min. The tissue was then incubated with rabbit polyclonal anti-CGRP (Biogenesis, Ltd., Oxford, UK) antiserum at a dilution of 1:300 or rabbit polyclonal anti-NPY (Phoenix Pharmaceuticals, Inc., Belmont, CA, USA) antiserum at a dilution of 1:300 for 72 h at 4°C. Thereafter, to detect the sites of the antigen-antibody reaction, the artery was incubated with fluorescein-5-isothiocyanate (FITC)-labeled goat anti-rabbit IgG (diluted 1:100) (ICN Pharmaceuticals Inc., Aurora, OH, USA) for 60 min, mounted on a slide, cover-slipped with glycerol / PBS (2:1 v / v), and observed under a confocal laser scanning microscope (CLSM510; Carl Zeiss, Tokyo) at the Okayama University Medical School Central Research Laboratory.
Immunohistochemical analysis
The immunostaining density of CGRP-like immunoreactive (CGRP-LI) and NPY-like immunoreactive (NPY-LI) nerve fibers was analyzed using the method described by Hobara et al. (11 -13) . Since the fluorescence intensity differed depending on the day of the experiment, the mesenteric arteries from rats treated with each drug after topical phenol treatment on Day 7 and vehicle-treated control rats were isolated, fixed, and immunostained at the same time on the same day and mounted on the same slide glass, while the vehicletreated rats at Day 7 were used as a control for the intensity in each experiment. For quantitative evaluation of CGRP-LI and NPY-LI, confocal projection images of CGRP and NPY immunostaining, which consisted of 8 -10 overlapping images (0.1 μm scanning) patched together, were magnified 20× and digitized as TIF images using a digital camera system (Olympus SP-1000; Olympus, Tokyo) and imported into a Windows XP computer (Toshiba, Tokyo). The stored digital images were analyzed using image-processing software (Simple PCI; Compix, Inc., Imaging Systems, Cranberry Township, PA, USA). The extraction of specific color and measured field commands were used to extract the CGRP-LI and NPY-LI areas (which were stained green). Extraction of the signal was carried out using specific protocols based on the hue, lightness, and saturation color parameters. A measured field of 100 μm × 100 μm (10000 μm 2 , which contained the adventitia layer including immunostained perivascular nerve fibers), was randomly selected on magnified images of the whole mount artery. The objective areas command was used to calculate the percentage of the CGRP-LI-and NPY-LIpositive area. The intensity of staining was estimated using a point-counting computer program and the background level was subtracted from the experimental value to yield the corrected intensity. The average density in three arteries was taken as the nerve density per animal.
To determine the number of CGRP-LI and NPY-LI fibers, five horizontal lines were drawn on the image of the blood vessel in the same region where the density was estimated by computer analysis. Then, the number of fibers that crossed each line was counted and the average of the number in 3 arteries was taken as the total number of fibers per animal.
Perfusion of mesenteric vascular beds
The animals were anesthetized with sodium pentobarbital (50 mg / kg, intraperitoneally) and the mesenteric vascular bed was isolated and prepared for perfusion as described previously (9, 14) . The isolated mesenteric vascular bed was separated from the intestine by cutting close to the intestinal wall. Only four main arterial branches from the superior mesenteric trunk running to the terminal ileum were perfused with a modified (see below) Krebs-Ringer bicarbonate solution (Krebs solution). The isolated mesenteric vascular bed was then placed on a water-jacketed organ bath maintained at 37°C and perfused with Krebs solution at a constant flow rate of 5 ml/ min with a peristaltic pump (model AC-2120; ATTO Co., Tokyo) and superfused with the same solution at a rate of 0.5 ml / min to prevent drying. The Krebs solution was bubbled with a mixture of 95% O 2 plus 5% CO 2 before passage through a warming coil maintained at 37°C. The modified Krebs solution had the following composition: 119.0 mM NaCl, 4.7 mM KCl, 2.4 mM CaCl 2 , 1.2 mM MgSO 4 , 25.0 mM NaHCO 3 , 1.2 mM KH 2 PO 4 , 0.03 mM EDTA2Na, and 11.1 mM glucose (pH 7.4). Changes in the perfusion pressure were measured with a pressure transducer (model TP-400T; Nihon Kohden, Tokyo) and recorded using a pen recorder (model U-228; Nippon Denshi Kagaku, Tokyo).
Perivascular nerve stimulation (PNS) and bolus injection of norepinephrine or CGRP
After allowing the basal perfusion pressure to stabilize, to observe adrenergic nerve-mediated vasoconstriction, the preparation was initially subjected to PNS at 8 and 12 Hz and bolus injections of norepinephrine (5 and 10 nmol). Thereafter, to observe CGRPergic nervemediated vasodilation, the preparation was contracted with an α 1 -adrenoceptor agonist, methoxamine (7 μM), in the presence of an adrenergic neuron blocker, guanethidine (5 μM), which was added to block the adrenergic neurotransmission. The increased perfusion pressure was allowed to stabilize, and the preparation was again subjected to PNS at 2 and 4 Hz and a bolus injection of CGRP (50 and 100 pmol). PNS was applied by using bipolar platinum ring electrodes placed around the superior mesenteric artery. Rectangular pulses of 1 ms and supramaximal voltage (50 V) were given for 30 s using an electronic stimulator (model SEN 3301, Nihon Kohden). Norepinephrine and CGRP were injected directly into the perfusate proximal to the arterial cannula with an infusion pump. A volume of 100 μL was injected for 12 s.
At the end of each experiment, preparations were perfused with 100 μM papaverine to cause complete relaxation. Vasodilator activity is expressed as the percentage of the perfusion pressure at the maximum relaxation induced by papaverine. Vasoconstrictor activity is expressed as a percent of the perfusion pressure.
Primary cultures of DRG cells
Rat DRG neurons were isolated from adult male Wistar rats (age: 6 -12 weeks), using procedures that have been reported previously (15, 16) . First, animals were anesthetized with a large dose of sodium pentobarbital, intraperitoneally. Then, the spinal cord was isolated and the ganglia were dissected using microforceps. After removal of connective tissue, the spinal roots were cut close to the ganglia, rapidly replaced in collagenase (5 mg / mL for 30 min at room temperature) (Sigma Aldrich Japan) followed by incubation for 30 min at 37°C with trypsin (Invitrogen Japan, Tokyo) and collagenase 1.25 and 2.5 mg / mL, respectively. The ganglia suspended with PBS was collected by centrifugation and mechanically dissociated by pipetting with Dulbecco's modified Eagle's medium (DMEM) (GIBCO Invitrogen Japan, Tokyo) containing 10% fetal bovine serum (GIBCO Invitrogen Japan), 100 U / mL penicillin, and 100 μg / mL streptomycin. The resulting cell suspensions were plated on serum-coated Petri dishes to allow the non-neuronal cells to adhere. After 90 min, the neurons in suspension were collected and plated on poly-L-lysine (10 μg / mL, Sigma Aldrich Japan)-coated 18-mm glass coverslips and maintained for 4 days at 37°C in a humidified incubator gassed with 5% CO 2 and air.
Cell treatments
To examine whether the HGF induce neurite outgrowth on DRG cells, cells were incubated without NGF or HGF (control cells), with NGF (100 ng / mL) or HGF (25 or 50 ng / mL). The substances were added to the neurons from the second day for 3 days and the medium was replaced every day.
Immunocytochemical experiments
For immunocytochemistry, cells were fixed with 10% formalin for 20 min following incubation with 0.5% TritonX-100 for 10 min. After washing with PBS, cells were incubated with 5% goat serum containing 1% BSA and NaN 3 for 30 min at room temperature. Thereafter, the cells were incubated with 1:500 diluted anti CGRP rabbit (Biomol International LP, CA, USA) for 60 min at room temperature. After washing cells were incubated for 40 min at room temperature with a (FITC)-labeled goat anti-rabbit IgG (MP Biomedicals, LLC, Tokyo), diluted 1:100 in PBS. After washing with PBS and distilled water, 2 -3 drops of Fluoromount (Cosmo Bio Co., Ltd., Tokyo), which prevents fading of fluorescent dyes, were put on the glass cover-slips, which were then gently applied to the slide glass. CGRP-immunopositive cells were approximately 40% of DRG neurons as reported by De Jonge et al. (15) .
To quantify neurite outgrowth in neurons, images of randomly chosen fields of neuron cultures were obtained with a Zeiss Axioplan (ZEISS, Germany) and OLYMPUS DP-50 camera units (Olympus Co., Japan); experiments were performed at the Central Research Laboratory, Okayama University Medical School. Quantification of neurite length was done on exported TIFF files using FluorchemTM8900 (Alpha Innotech, San Leandro, CA, USA). Briefly, the longest neurite length was measured from the center of the cell body and counted as neurite outgrowth.
Statistical analyses
All data are expressed as the mean ± S.E.M. Analysis of variance (ANOVA) followed by Tukey's test was used to determine statistical significance where appropriate. Correlation analysis was carried out using Pearson's correlation test. P<0.05 was considered statistically significant.
Results
Changes in innervation of CGRP-LI-or NPY-LI nerve fibers in mesenteric arteries following phenol treatment with or without HGF or NGF administration
As shown in Fig. 1A , the distal mesenteric artery was densely innervated by CGRP-LI nerve fibers, and the density and number of CGRP-LI nerves were lower than that of NPY-LI nerves (Fig. 2A) . The density of CGRP-LI nerve fibers in the distal small artery was markedly decreased by approximately 80% after topical phenol treatment of the superior mesenteric artery (Fig. 1B) , whereas the vehicle (saline or 90% alcohol) treatment (Sham control) did not reduce the innervation of CGRP-LI nerve fibers (Fig. 1A) .
As shown in Fig. 1 (C, F, and G) , administration of HGF at a dose of 10 μg/ kg per day had no effect on the density or number of CGRP-LI nerve fibers, whereas administration of HGF at a dose of 30 μg / kg per day increased the density and number compared with the Phenol-Saline group (Fig. 1: D, F, and G) . NGF administration after topical application of phenol significantly increased the density and number compared with the Phenol-Saline group. NGF restored the level of innervation of CGRP-LI nerve fibers to the level observed in the Sham control group (Fig. 1: E -G) .
As shown in Fig. 2A , the distal mesenteric artery was densely innervated by NPY-LI nerve fibers, and the density or number of NPY-LI nerves was much higher than that of CGRP-LI nerves (Fig. 1A) . The density and number of NPY-LI nerve fibers in the distal small arteries were significantly decreased at 7 days after topical phenol application in the superior mesenteric artery (Fig. 2: B , F, and G). Administration of HGF at doses of 10 and 30 μg / kg per day caused no significance change in the density or number of NPY-LI fibers compared with the Phenol-Saline group (Fig. 2: C, D, F , and G). However, the decreased level of NPY-LI fiber density and number following phenol treatment were restored by the application of NGF (20 μg / kg per day) to the level in the Sham control group (Fig. 2 : E, F, and G).
There was a significant difference between the density and number in the Phenol-Saline group and Phenol-NGF group ( Fig. 2: E, F, and G) . The relationships between the numbers of CGRP-LI and NPY-LI nerve fibers, which were visually counted, and the densities of CGRP-LI and NPY-LI nerves (%), Changes in systolic blood pressure (SBP) after phenol treatment
As shown in Table 1 , HGF dose-dependently lowered SBP on Day 7 after phenol treatment. NGF also decreased SBP on Day 7. Significant differences were found in SBP between Phenol-HGF treatment at a dose of 30 μg / kg per day or Phenol-NGF treatment and Phenol-Saline treatment.
Effects of HGF or NGF treatment on vasoconstrictor responses to PNS and bolus injection of norepinephrine to phenol treatment rats
As shown in Fig. 3 , PNS at 8 and 12 Hz of the perfused mesenteric vascular beds with resting tone produced a frequency-dependent increase in perfusion pressure due to vasoconstriction. The vasoconstrictor responses to PNS at 8 and 12 Hz in the Phenol-Saline group were smaller than those in the Sham group (Fig. 3) . Furthermore, in the Phenol-Saline and Phenol-HGF (10 or 30 μg/ kg per day) groups, the vasoconstrictor response to PNS at 12 Hz, but not 8 Hz, was also significantly smaller than the Sham group (Fig. 3) .
In the Phenol-NGF group, the vasoconstrictor response to PNS at 12 Hz was smaller than that in the Sham group, but there was no significant difference between the Phenol-NGF and Sham group. As shown in Fig. 3 , vasoconstrictor responses to bolus injections of norepinephrine were not significantly affected by treatment with Phenol-Saline, Phenol-HGF, or Phenol-NGF.
Effects of treatment with HGF or NGF on vasodilator responses to PNS or bolus injection of CGRP to phenol treatment rats
To maintain active tone of the mesenteric artery, each preparation was contracted by continuous perfusion of 7 μM methoxamine (α 1 -adrenergic receptor agonist) in the presence of 5 μM guanethidine (adrenergic neuron blocker), which was added to block adrenergic neurotransmission. In this preparation, PNS at 2 and 4 Hz caused a frequency-dependent decrease in perfusion pressure due to vasodilation. The vasodilator response to PNS has been shown to be mediated by CGRPergic nerves since the response was blocked by CGRP(8 -37) (CGRP-receptor antagonist) and capsaicin (CGRP depletor) (17, 18) . Bolus injections of CGRP also induced a concentration-dependent vasodilation, which has been shown to be mediated by postsynaptic CGRP receptors (19) .
Vasodilatations in responses to PNS (2 and 4 Hz) in Phenol-Saline-treated rat preparations were significantly smaller than those in Sham preparations (Fig. 4) . As shown in Figs. 4, the PNS-induced (1 Hz) vasodilator responses of preparations from Phenol-Saline, Phenol-HGF (10 or 30 μg / kg per day), and Phenol-NGF groups were similar in magnitude to Sham preparations. The vasodilator responses to PNS at 2 and 4 Hz in the Phenol-HGF (30 μg / kg per day but not 10 μg/ kg per day) group were greater than those in the Phenol-Saline group and no significant difference was found between the Sham and Phenol-HGF groups (Fig. 4) . The Phenol-NGF group showed PNS-induced vasodilator responses similar to those in the Phenol-HGF group. Bolus injection of CGRP at concentrations of 50 and 100 pmol produced long-lasting depressor responses, which mimicked PNS-induced vasodilation and was blocked by CGRP(8 -37) (data not shown). As shown in Fig. 4 , vasodilator responses to injected CGRP at any concentration in the Phenol-Saline group were of a similar degree to those in the Sham group. However, in the Phenol-HGF (10 or 30 μg / kg per day) group, 50 pmol CGRP-induced vasodilation was greater than that in the Phenol-Saline group, while the level of 100 pmol CGRP-induced vasodilation was the same as those in the Sham and Phenol-Saline groups. The vasodilation in response to CGRP (50 or 100 pmol) in the Phenol-NGF group was significantly smaller than that in the Sham group and Phenol-Saline group.
Effect of treatment with HGF or NGF on neurite outgrowth of DRG neurons
In cultured DRG cells, sizes of the CGRP-LI positive cell bodies were 20.3 ± 6.9 μm (n = 46). As shown in Fig. 5 , treatment with HGF at 25 or 50 ng / mL concentration-dependently increased neurite outgrowth in cultured DRG cells. Treatment with NGF at 100 ng/ mL also markedly increased neurite outgrowth. Extended neurite length induced by HGF at 25 and 50 ng / mL and NGF at 100 ng / mL were 82.5 ± 33.1, 118.2 ± 59.6, and 113.3 ± 26.5 μm, respectively. There was a significant difference between the control and HGF at 50 ng / mL, but not 25 ng / mL, or NGF at 100 ng/ mL. The immunostaining assay showed that outgrown neurites were CGRP-LI-positive (Fig. 5) .
Discussion
In the present study, topical application of phenol around the rat superior mesenteric artery in vivo resulted in marked reduction of both CGRP-LI and NPY-LI nerves, which innervated in the distal small mesenteric artery. This finding is in good accordance with our previous reports (10 -12) , supporting the fact that the method using phenol is effective for inducing perivascular denervation in vivo. The present study is the first to demonstrate that HGF facilitates reinnervation of perivascular CGRP-LI nerves injured by topical phenol treatment in the rat superior mesenteric artery. Our previous studies showed that phenol-induced reduction of perivascular innervation was prevented by NGF treatment (10) . Furthermore, adrenomedullin, a potent vasodilator peptide, facilitates the reinnervation of perivascular NPY-LI and CGRP-LI nerves injured by topical application of phenol in the rat mesenteric artery (11) . Taken together, it is likely that HGF, like NGF and adrenomedullin, has the ability to enhance reinnervation of the perivascular nerves. However, HGF seems to have a different action from NGF and adrenomedullin since HGF cancelled only the phenol-induced reduction of the innervation of CGRP-LI nerves without affecting NPY-LI. In the present study, a high dose of HGF after phenol treatment, which facilitated reinnervation of CGRP-LI nerves, restored the CGRPergic nerve-mediated vasodilator response to PNS of perfused mesenteric vascular beds, suggesting that the vasodilator function of CGRPergic nerves is recovered by HGF. However, adrenergic nerve-mediated vasoconstrictor responses by PNS were not affected by treatment of HGF, which had no effect on reinnervation of sympathetic NPY-LI nerves. These functional results are well correlated with results obtained by immunohistochemical studies. These results suggest that HGF accelerates only reinnervation and/ or regenerations of CGRPergic vasodilator nerves and restores their vasodilator function. Interestingly, the present study showed that the Phenol-HGF-treated group had lower systolic blood pressure compared with the Phenol-Saline-treated group. Therefore, it is assumed that the blood pressure lowering effect may result from restored CGRPergic nerve function by HGF since HGF had no effect on injured NPY-LI adrenergic vasoconstrictor nerves. However, consistent with the present finding, a high concentration of serum HGF has been reported to decrease blood pressure (20, 21) . It is possible that HGF by itself has a blood pressurelowering effect.
It should be noted that HGF has a facilitatory effect on reinnervation of perivascular CGRPergic nerves, but not sympathetic adrenergic nerves. Maina et al. (22) reported that HGF alone did not facilitate neurite outgrowth in cultured DRG neurons, while it can enhance the proliferation of sensory neurons induced by NGF. Therefore, HGF seems to have a synergic effect with NGF. However, Yang et al. (23) reported that C-Met levels, which activate HGF receptors, are very low in sympathetic cells. It seems likely that low C-Met activation in sympathetic neurons may result in undetectable effects of HGF on reinnervation of sympathetic adrenergic nerves.
In primary DRG cell culture study, HGF treatment like NGF treatment resulted in CGRP-LI nerve elongation from DRG cells. These in vitro findings support our present results that HGF has specific neurotrophic effect on CGRP-LI fibers in the mesenteric artery. However, it is still unclear whether HGF acts directly or indirectly on DRG neurons. Hashimoto et al. (24) reported that c-Met mRNA was not detected in DRG but was detected in the spinal dorsal horn. Therefore, it is possible that HGF might act on glia cells, which release trophic factors such as NGF, neurotrophine-3, and brain-derived neurotrophic factor. Our findings showed that HGF alone was effective to promote axonal outgrowth in adult rat cultured DRG neurons. However, HGF has been reported to have no outgrowth promoting activity in mouse cultured embryonic DRG neurons (22) . The difference between the present observations and other reported results may be the HGF concentrations used. In the study on mouse embryonic cells, HGF at a concentration of 12 ng / mL was used, while the present study showed no significant increase in neurite outgrowth at 25 ng / mL concentration.
In conclusion, the present results suggest that HGF facilitates the reinnervation of CGRP-LI nerve fibers injured by topical phenol treatment. The results also suggest that HGF, like NGF, has the ability to regenerate and/ or reinnervate perivascular nerves as a neurotrophic factor.
